Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Adam

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 FusionsJulien Adam, Nolwenn Le Stang, Arnaud Uguen, et al.
Cancers|December 17, 2020
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung CancerArthur Geraud, Laura Mezquita, Edouard Auclin, et al.
Nature Communications|December 4, 2018
Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumoursAurélie Durgeau, Yasemin Virk, Gwendoline Gros, et al.
Journal of Crohn'S & Colitis|October 3, 2017
Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological EntitiesClélia Coutzac, Julien Adam, Emilie Soularue, et al.
BMC Cancer|July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancerMathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
Cancer Medicine|November 25, 2020
Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcomaAudrey Perret, Julien Dômont, Ali N Chamseddine, et al.
Ebiomedicine|November 30, 2020
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapiesMaud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke, et al.
ESMO Open|January 19, 2018
TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinomaCharlotte Leduc, Julien Adam, Emilie Louvet, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal MetastasesRonan Flippot, Pamela Biondani, Edouard Auclin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2021
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapyIthar Gataa, Laura Mezquita, Caroline Rossoni, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 FusionsJulien Adam, Nolwenn Le Stang, Arnaud Uguen, et al.
Cancers|December 17, 2020
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung CancerArthur Geraud, Laura Mezquita, Edouard Auclin, et al.
Nature Communications|December 4, 2018
Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumoursAurélie Durgeau, Yasemin Virk, Gwendoline Gros, et al.
Journal of Crohn'S & Colitis|October 3, 2017
Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological EntitiesClélia Coutzac, Julien Adam, Emilie Soularue, et al.
BMC Cancer|July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancerMathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
Cancer Medicine|November 25, 2020
Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcomaAudrey Perret, Julien Dômont, Ali N Chamseddine, et al.
Ebiomedicine|November 30, 2020
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapiesMaud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke, et al.
ESMO Open|January 19, 2018
TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinomaCharlotte Leduc, Julien Adam, Emilie Louvet, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal MetastasesRonan Flippot, Pamela Biondani, Edouard Auclin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2021
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapyIthar Gataa, Laura Mezquita, Caroline Rossoni, et al.
Pageof 16